- Akums Drugs & Pharmaceuticals intends to expand globally and increase product range to more than quadruple its turnover to Rs 10,000 crore by 2028, according to Joint Managing Director Sandeep Jain.
- The company’s 15 production facilities manufacture around 12% of all pharmaceuticals consumed in the country.
- From our current level of Rs 4,000 crore, we expect to reach Rs 10,000 crore by 2028. Our goal is 12-15 CAGR “”Jain”
